BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12793432)

  • 1. [Editorial comment: mobile telephones and implantable cardioverter-defibrillators].
    Demirkan D
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):49. PubMed ID: 12793432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Do mobile telephones have adverse effects on the functions of implantable cardioverter defibrillators?].
    Tandoğan I; Ileri M; Yetkin E; Temizhan A; Aras D; Sezgin AT; Biyikoğlu F; Saşmaz A
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):45-8, AXVII. PubMed ID: 12101794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillators.
    Chiladakis JA; Davlouros P; Agelopoulos G; Manolis AS
    Eur Heart J; 2001 Aug; 22(15):1337-42. PubMed ID: 11465966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of two common European digital cellular phones with implantable cardioverter-defibrillators.
    Niehaus M; Gille R; Cierpka R; Korte T; Tebbenjohans J
    Eur Heart J; 2002 Apr; 23(7):586-8; dicussion 588. PubMed ID: 11922650
    [No Abstract]   [Full Text] [Related]  

  • 5. How to avoid inappropriate therapy.
    Israel CW
    Curr Opin Cardiol; 2008 Jan; 23(1):65-71. PubMed ID: 18281830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillators and cellular telephones: is there any interference?
    Occhetta E; Plebani L; Bortnik M; Sacchetti G; Trevi G
    Pacing Clin Electrophysiol; 1999 Jul; 22(7):983-9. PubMed ID: 10456625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is there any risk interaction between electromagnetic field generated by mobile phones and artificial pacemakers].
    Derkacz A; Poreba R; Skoczyńska A; Andrzejak R
    Med Pr; 2001; 52(2):107-10. PubMed ID: 11761658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital cellular telephones and ICDs.
    Santini M
    Eur Heart J; 2001 Aug; 22(15):1251-2. PubMed ID: 11465959
    [No Abstract]   [Full Text] [Related]  

  • 9. Avoidance of electromagnetic interference to implantable cardiovertor-defibrillator during atrioventricular node ablation for atrial fibrillation using transvenous cryoablation.
    Siu CW; Tse HF; Lau CP
    Pacing Clin Electrophysiol; 2006 Aug; 29(8):914-6. PubMed ID: 16923011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can a person with a pacemaker use and receive calls via a cellular telephone?].
    Passchier WF
    Ned Tijdschr Geneeskd; 2000 Mar; 144(10):490. PubMed ID: 10766600
    [No Abstract]   [Full Text] [Related]  

  • 11. Interference of electrical dental equipment with implantable cardioverter-defibrillators.
    Brand HS; Entjes ML; Nieuw Amerongen AV; van der Hoeff EV; Schrama TA
    Br Dent J; 2007 Nov; 203(10):577-9. PubMed ID: 18037843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The absence of interference between GSM mobile telephones and implantable defibrillators: an in-vivo study. Groupe Systèmes Mobiles].
    Sanmartín M; Fernández Lozano I; Márquez J; Antorrena I; Bautista A; Silva L; Ortigosa J; de Artaza M
    Rev Esp Cardiol; 1997 Oct; 50(10):715-9. PubMed ID: 9417561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac pacemakers and cellular telephones.
    Roelke M; Bernstein AD
    N Engl J Med; 1997 May; 336(21):1518-9. PubMed ID: 9154773
    [No Abstract]   [Full Text] [Related]  

  • 14. Electromagnetic interference of digital and analog cellular telephones with implantable cardioverter defibrillators: in vitro and in vivo studies.
    Barbaro V; Bartolini P; Bellocci F; Caruso F; Donato A; Gabrielli D; Militello C; Montenero AS; Zecchi P
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):626-34. PubMed ID: 10234716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of electromagnetic interference on implanted cardiac devices and their management.
    Yerra L; Reddy PC
    Cardiol Rev; 2007; 15(6):304-9. PubMed ID: 18090066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment.
    Goldschlager N; Epstein A; Friedman P; Gang E; Krol R; Olshansky B;
    Arch Intern Med; 2001 Mar; 161(5):649-55. PubMed ID: 11231696
    [No Abstract]   [Full Text] [Related]  

  • 17. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
    O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative management of patients with implantable cardioverter defibrillators.
    Donnelly P; Pal N; Herity NA
    Ulster Med J; 2007 May; 76(2):66-7. PubMed ID: 17476818
    [No Abstract]   [Full Text] [Related]  

  • 19. Hazards of antitachycardia pacing to treat ventricular tachycardias with implantable cardioverter defibrillators.
    Maass AH; Van Gelder IC
    Europace; 2009 Jun; 11(6):819. PubMed ID: 19357140
    [No Abstract]   [Full Text] [Related]  

  • 20. Implantable rhythm devices and electromagnetic interference: myth or reality?
    Dyrda K; Khairy P
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):823-32. PubMed ID: 18570620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.